460.75
Schlusskurs vom Vortag:
$458.60
Offen:
$459.54
24-Stunden-Volumen:
1.08M
Relative Volume:
1.00
Marktkapitalisierung:
$99.75B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
15.85
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+6.61%
1M Leistung:
+7.92%
6M Leistung:
-7.37%
1J Leistung:
+12.19%
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, EHC, DVA, FMS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HCA
Hca Healthcare Inc
|
460.75 | 99.75B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
266.91 | 21.49B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
124.33 | 12.27B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
DVA
Davita Inc
|
182.08 | 11.62B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.08 | 11.22B | 22.44B | 1.35B | 2.03B | 1.9002 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-07-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus - Zacks Investment Research
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
WBO:HCAH Dividend: Does HCA Healthcare Inc Pay a Dividend? - GuruFocus
Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today? - Moomoo
HCA Healthcare, Inc. $HCA Shares Sold by Bell Asset Management Ltd - MarketBeat
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA Healthcare stock stands at EUR 396.50 with USD 96.2 billion market value - AD HOC NEWS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc.HCA - PR Newswire
Former HCA executive gifts $1.5M to Belmont's Thomas F. Frist Jr. College of Medicine - The Business Journals
2,528 Shares of HCA Healthcare, Inc. $HCA Bought by Canandaigua National Trust Co of Florida - MarketBeat
HCA Healthcare (HCA) Could Be 3% Undervalued As Breast Imaging Expansion Continues - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare
Royal Bank Of Canada Forecasts Strong Price Appreciation for HCA Healthcare (NYSE:HCA) Stock - MarketBeat
HCA Healthcare Presents 2026 Awards of Distinction - Florida Hospital News and Healthcare Report
HCA Healthcare's Q3 2026 Earnings: What to Expect - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Park National Corp OH Purchases 6,276 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
65,181 HCA Healthcare, Inc. $HCA Shares Sold by Argent Capital Management LLC - MarketBeat
DAI Closes HCA Hospice, Home Health Transaction - Hospice News
Raymond James rates HCA Healthcare stock Market Perform - AD HOC NEWS
Weekly Recap: AI lift to HCA Healthcare earnings and Oct 27 earnings call - TradingView
HCA Healthcare, Inc. Common Stock (NYSE:HCA) Stock Quote - FinancialContent
CX Institutional Lowers Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA closes home health, hospice sale to Deaconess - Modern Healthcare
Cantor Fitzgerald reiterates HCA Healthcare stock Overweight rating - Investing.com
HCA Healthcare (NYSE:HCA) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
HCA Healthcare brings back former exec to lead StoneSprings Hospital - The Business Journals
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Houston and Cigna locked in new contract dispute with deal set to expire - The Business Journals
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy? - Zacks Investment Research
Price to earnings forward of HCA Healthcare Inc – HAN:2BH - TradingView
HCA Healthcare Presents 2026 Awards of Distinction - Business Wire
ETFs Investing in HCA Healthcare Inc Stocks - TradingView
Can HCA Healthcare (HCA) Overcome Healthcare’s Margin Pressures? - Yahoo Finance
HCA's StoneSprings Hospital drops plan for freestanding ER in Chantilly - The Business Journals
Raymond James assumes Market Perform on HCA Healthcare stock citing industry headwinds - Investing.com
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
Can Community Health Sustain Growth as Elective Demand Softens? - TradingView
Can Community Health Sustain Growth as Elective Demand Softens? - TradingView
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - webull.com
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare faces securities fraud investiga... - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc.HCA - PR Newswire
Can HCA Sustain Earnings Growth Despite a Changing Service Mix? - TradingView
Can HCA Sustain Earnings Growth Despite a Changing Service Mix? - TradingView
HCA Healthcare (NYSE:HCA) Upgraded at BMO Capital Markets - MarketBeat
QRG Capital Management Inc. Lowers Position in HCA Healthcare, Inc. $HCA - MarketBeat
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Michael R McAlevey | OFFICER |
Feb 18 '26 |
Proposed Sale |
533.34 |
1,694 |
903,486 |
0 |
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
| Wyatt Christopher F. | SVP & Controller |
Feb 11 '26 |
Sale |
505.00 |
4,000 |
2,020,000 |
44,379 |
| Berres Jennifer | SVP & Chief Human Res. Officer |
Feb 11 '26 |
Sale |
514.58 |
8,020 |
4,126,950 |
11,993 |
| Jennifer L. Berres | OFFICER |
Feb 11 '26 |
Proposed Sale |
514.58 |
8,020 |
4,126,950 |
0 |
| Wyatt Christopher F. | SVP & Controller |
Feb 05 '26 |
Option Exercise |
139.06 |
10,670 |
1,483,770 |
51,737 |
| Foster Jon M | EVP and COO |
Feb 05 '26 |
Option Exercise |
139.06 |
29,330 |
4,078,630 |
29,330 |
| Cuffe Michael S. | EVP and Chief Clinical Officer |
Feb 03 '26 |
Sale |
498.09 |
1,500 |
747,135 |
30,003 |
| HAZEN SAMUEL N | CEO |
Feb 03 '26 |
Sale |
501.04 |
42,877 |
21,483,275 |
32,276 |
| MICHAEL S CUFFE | OFFICER |
Feb 03 '26 |
Proposed Sale |
498.09 |
1,500 |
747,135 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):